CADL icon

Candel Therapeutics

21 hedge funds and large institutions have $7.44M invested in Candel Therapeutics in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership:

more funds holding

Funds holding:

more funds holding in top 10

Funds holding in top 10:

more first-time investments, than exits

New positions opened: | Existing positions closed:

23% less capital invested

Capital invested by funds: $9.7M → $7.44M (-$2.26M)

25% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 4

Holders
21
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$143K
2 +$64.6K
3 +$34.3K
4
Renaissance Technologies
Renaissance Technologies
New York
+$28K
5
BlackRock
BlackRock
New York
+$10.1K

Top Sellers

1 -$170K
2 -$24K
3 -$20.1K
4
UBS Group
UBS Group
Switzerland
-$1.1K
5
TRCT
Tower Research Capital (TRC)
New York
-$873
Name Holding Trade Value Shares
Change
Change in
Stake
1
$2.61M
2
$1.54M
3
$1.1M
4
$840K
5
$548K
6
$182K
7
$180K
8
$143K
9
$64.6K
10
$62.8K
11
$37.8K
12
$34.3K
13
$28K
14
$26.5K
15
$16.2K
16
$15.6K
17
$9K
18
$246
19
$135
20
$14
21
22
23
24